Skip to content

10-Panel High-Sensitivity Opiate Compact Drug Test Cup – 90 mL | AMP, BAR, BUP, BZO, COC, MET, MTD, OPI, OXY & THC

In Stock

$5.99$2.60/each

Buy More, Save More
Quantity
1

Description

10 DRUG PANELS • HIGH-SENSITIVITY OPI/300 • COMPACT 90 mL

10-Panel High-Sensitivity Opiate Compact Drug Test Cup

Comprehensive preliminary urine drug screening with a sensitive OPI/300 panel in a compact 90 mL cup.

This self-contained test cup screens for amphetamines, barbiturates, buprenorphine, benzodiazepines, cocaine, methamphetamine, methadone, opiates, oxycodone and marijuana.

The OPI/300 panel uses a lower manufacturer-listed cutoff than a standard OPI/2000 configuration, supporting more sensitive preliminary opiate screening. Collection, temperature verification and ten-panel testing take place in one compact device, with results available in approximately five minutes.

Product Highlights

Ten-Drug Screening Screens for AMP, BAR, BUP, BZO, COC, MET, MTD, OPI, OXY and THC.
High-Sensitivity OPI/300 Screens morphine and related opiates at the manufacturer-listed 300 ng/mL cutoff.
Dedicated Buprenorphine Panel Screens for buprenorphine at the listed 10 ng/mL cutoff.
Dedicated Oxycodone Panel Includes separate oxycodone screening at the listed 100 ng/mL cutoff.
Expanded Opioid Coverage Includes separate BUP, MTD, OPI and OXY panels.
Results in Minutes Provides clear preliminary results in approximately five minutes.
Compact 90 mL Capacity Provides practical specimen capacity in an easy-to-store format.
One-Step Testing Collection and preliminary screening are completed using one device.
Leak-Resistant Lid Secure no-drip twist closure helps reduce leaks and accidental spills.
Built-In Temperature Strip Supports prompt verification that specimen temperature is within the expected range.
Manufacturer-Stated Accuracy Manufacturer information reports up to 99% accuracy when used as directed.
Same-Day Shipping Eligible orders placed within the applicable processing window ship the same business day.
Ten Drug Panels with High-Sensitivity OPI/300 Screening A compact option for healthcare facilities, occupational health clinics, treatment programs, collection sites, correctional settings and authorized workplace screening.

Drug Panels and Cutoff Levels

Review the ten drug categories and manufacturer-listed preliminary screening cutoff levels.

TEST STRIP TESTED DRUG ESTIMATED DETECTION TIME / CUTOFF
AMP   AMP   AMP   AMP   AMP
AMP   AMP   AMP   AMP   AMP
 Amphetamines 1–2 Days • 1,000 ng/mL
BAR   BAR   BAR   BAR   BAR
BAR   BAR   BAR   BAR   BAR
 Barbiturates 1–2 Days • 300 ng/mL
BUP   BUP   BUP   BUP   BUP
BUP   BUP   BUP   BUP   BUP
 Buprenorphine 2–6 Days • 10 ng/mL
BZO   BZO   BZO   BZO   BZO
BZO   BZO   BZO   BZO   BZO
 Benzodiazepines 1–2 Days • 300 ng/mL
COC   COC   COC   COC   COC
COC   COC   COC   COC   COC
 Cocaine 2–4 Days • 300 ng/mL
MET   MET   MET   MET   MET
MET   MET   MET   MET   MET
 Methamphetamine 2–4 Days • 1,000 ng/mL
MTD   MTD   MTD   MTD   MTD
MTD   MTD   MTD   MTD   MTD
 Methadone 1–3 Days • 300 ng/mL
OPI   OPI   OPI   OPI   OPI
OPI   OPI   OPI   OPI   OPI
 Morphine / Opiates 2–3 Days • 300 ng/mL
OXY   OXY   OXY   OXY   OXY
OXY   OXY   OXY   OXY   OXY
 Oxycodone 1–3 Days • 100 ng/mL
THC   THC   THC   THC   THC
THC   THC   THC   THC   THC
 Marijuana 5+ Days • 50 ng/mL
Please Note: Detection windows vary according to dosage, frequency of use, metabolism, hydration, body composition, specimen concentration and other individual factors.  Refer to the manufacturer’s package insert for exact cutoff levels, cross-reactivity and interpretation instructions.
What High-Sensitivity OPI/300 Means This opiate panel uses a 300 ng/mL preliminary screening cutoff, compared with higher-cutoff configurations such as OPI/2000. It should not be interpreted as a quantitative measurement or a final laboratory result.
Separate BUP, MTD, OPI and OXY Panels Buprenorphine, methadone and oxycodone may not be detected with equal sensitivity by a traditional opiate panel. Dedicated strips provide targeted preliminary screening for each listed analyte.
Compact Testing Format The 90 mL design integrates specimen collection, temperature verification and ten-panel screening while requiring less storage space than a standard-size cup.

How to Use the 10-Panel High-Sensitivity Opiate Compact Drug Test Cup

Understanding the 10-Panel High-Sensitivity Opiate Compact Drug Test Cup Results


Product Dimensions and Specifications

10-Panel High-Sensitivity Opiate Compact Drug Test Cup
Drug panels AMP, BAR, BUP, BZO, COC, MET, MTD, OPI, OXY and THC
Opiate cutoff OPI/300
Buprenorphine cutoff BUP/10
Methadone cutoff MTD/300
Oxycodone cutoff OXY/100
Result time Approximately 5 minutes
Capacity 90 mL
Height 2.53 inches
Bottom width 2.12 inches
Lid width 2.75 inches
Approximate weight 0.14 lb

CLIA Waived and FDA 510(k) Cleared

According to the supplied manufacturer information, this exact 10-panel configuration is CLIA Waived and FDA 510(k) Cleared for the intended uses identified in its labeling. Verify the regulatory status printed on the exact product packaging before advertising or use.

What CLIA Waived Means Eligible point-of-care sites may use the test under a CLIA Certificate of Waiver when the manufacturer’s instructions and applicable requirements are followed.
What FDA 510(k) Cleared Means The device completed the applicable FDA premarket-clearance process for the intended uses identified in its authorized labeling.

Depending on its exact labeling and applicable requirements, this cup may be suitable for physician offices, occupational health clinics, treatment and rehabilitation programs, collection sites, probation and correctional programs, law-enforcement settings and qualifying workplace-screening programs.

Regulatory Notice: FDA clearance and CLIA-waived status are separate designations. State and local requirements may apply, and regulatory status can vary by exact cup configuration or individual assay.

Frequently Asked Questions

1. Which drugs does this 10-panel cup screen for? It screens for amphetamines, barbiturates, buprenorphine, benzodiazepines, cocaine, methamphetamine, methadone, opiates, oxycodone and marijuana.
2. What does high-sensitivity OPI/300 mean? It means the morphine and opiate panel uses a manufacturer-listed preliminary screening cutoff of 300 ng/mL, which is lower than an OPI/2000 configuration.
3. Why are BUP, MTD, OPI and OXY tested separately? Buprenorphine, methadone and oxycodone may not be detected with equal sensitivity by a standard opiate panel. Dedicated strips provide targeted preliminary screening.
4. How quickly are results available? Preliminary results are available in approximately five minutes. Do not interpret results after eight minutes or outside the manufacturer’s stated reading window.
5. Does the temperature strip prove specimen authenticity? No. It measures specimen temperature shortly after collection and helps identify samples outside the expected temperature range. It does not independently prove authenticity or detect dilution.
6. Is a presumptive positive result final? No. Presumptive positive results should be confirmed using an appropriate laboratory method before clinical, employment, treatment or legal decisions are made.
Ten Drug Panels. High-Sensitivity OPI/300 Screening. Compact 90 mL Design. Simplify preliminary urine drug screening with a compact, self-contained cup designed for secure collection, rapid results and expanded opioid-related coverage.
Order 10-Panel Compact Test Cups Today

Shipping & Delivery

  • All orders will be shipped the same day if placed before 3:00 PM EST.
  • Next-day shipments will not be delivered on weekends, and the time taken on air shipments should be counted as business days.

Why order from us

  • CLIA-waived screening supplies for qualified lab and point-of-care workflows.
  • Same-day shipping on orders placed before 3:00 PM EST.
  • Volume and bulk pricing available — contact us for recurring supply.